Patents by Inventor Bjorn A. TRAAG
Bjorn A. TRAAG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20250066717Abstract: The present invention provides a composition comprising a biologically pure culture of a Paenibacillus sp. strain comprising a mutant DegU lacking a functional receiver domain or a functional DNA binding domain and/or a mutant DegS lacking a functional single binding domain or a functional ATPase domain with decreased viscosity in a liquid culture. Also provided is a method of identifying a Paenibacillus sp. mutant derivative strain with decreased viscosity in a liquid culture compared to a Paenibacillus sp. parental strain with a visual screen for mutant isolates with a non-mucoid morphology.Type: ApplicationFiled: November 14, 2024Publication date: February 27, 2025Inventors: Jennifer Anne COLLINS, Jesus F. SANCHEZ, James L. WALLER, Bjorn A. TRAAG, Sara K. HOTTON, Tony J. TEGELER
-
Patent number: 12173278Abstract: The present invention provides a composition comprising a biologically pure culture of a Paenibacillus sp. strain comprising a mutant DegU lacking a functional receiver domain or a functional DNA binding domain and/or a mutant DegS lacking a functional single binding domain or a functional ATPase domain with decreased viscosity in a liquid culture. Also provided is a method of identifying a Paenibacillus sp. mutant derivative strain with decreased viscosity in a liquid culture compared to a Paenibacillus sp. parental strain with a visual screen for mutant isolates with a non-mucoid morphology.Type: GrantFiled: May 8, 2019Date of Patent: December 24, 2024Assignee: Bayer CropScience LPInventors: Jennifer Anne Collins, Jesus F. Sanchez, James L. Waller, Bjorn A. Traag, Sara K. Hotton, Tony J. Tegeler
-
Publication number: 20230322641Abstract: Described herein are methods and compositions that utilize microorganisms integrated with plants for improvement of carbon dioxide conversion and sequestration in soil.Type: ApplicationFiled: April 17, 2023Publication date: October 12, 2023Inventors: Gonzalo FUENZALIDA, Tania TIMMERMANN, Bjorn TRAAG, Lina LEON, Naresh PANDEY, Raghuveer SINGH
-
Publication number: 20230234988Abstract: The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof comprising at least one Paeniserine and at least one Paeniprolixin. Also provided are isolated compounds and methods of treating a plant to control a plant disease with the disclosed compositions and compounds.Type: ApplicationFiled: February 27, 2023Publication date: July 27, 2023Inventors: Jeremy BEAU, Daniel M. JOO, Patrick SCHWIENTEK, Colleen S. TAYLOR, Bjorn A. TRAAG
-
Patent number: 11702665Abstract: Signal sequences useful for targeting proteins and peptides to the surface of endospores produced by Paenibacillus family members and methods of using the same are provided. The display of heterologous molecules, such as peptides, polypeptides and other recombinant constructs, on the spore surface of Paenibacillus family members, using particular N-terminal targeting sequences and derivatives of the same, are also provided.Type: GrantFiled: March 30, 2021Date of Patent: July 18, 2023Assignee: Ginkgo Bioworks, Inc.Inventors: Damian Curtis, Benjamin L. Golomb, Dilara Ally, Florencia A. Ficarra, Rauf Salamzade, Bjorn A. Traag
-
Patent number: 11623944Abstract: The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof comprising at least one Paeniserine and at least one Paeniprolixin. Also provided are isolated compounds and methods of treating a plant to control a plant disease with the disclosed compositions and compounds.Type: GrantFiled: October 31, 2019Date of Patent: April 11, 2023Assignee: Bayer CropScience LPInventors: Jeremy Beau, Daniel M. Joo, Patrick Schwientek, Colleen S. Taylor, Bjorn A. Traag
-
Publication number: 20220151242Abstract: The present invention provides a composition comprising a biologically pure culture of a Paenibacillus sp. strain or a cell-free preparation thereof comprising a fusaricidin and a tridecaptin; wherein the fusaricidin is produced with a fusaricidin synthetase gene of fusA encoded by a DNA sequence exhibiting at least 90.5% sequence identity to SEQ ID NO: 3; and the tridecaptin is produced with a nonribosomal peptide synthetase (NRPS) gene of triE encoded by a DNA sequence exhibiting at least 90.0% sequence identity to SEQ ID NO: 7. Also provided are methods of treating an agricultural plant to control a disease and methods of increasing the vigor and/or crop yield of an agricultural plant with the disclosed compositions.Type: ApplicationFiled: March 5, 2020Publication date: May 19, 2022Inventors: Jeremy BEAU, Andreas GOERTZ, Adam NEWMAN, Patrick SCHWIENTEK, Colleen S. TAYLOR, Donglan TIAN, Bjorn A. TRAAG
-
Publication number: 20220007651Abstract: The present invention provides a composition comprising a biologically pure culture of a Bacillus thuringiensis strain or a cell-free preparation thereof comprising zwittermicin A, Vip3Aa11, Cry1Aa11, and Cry1Ab1. The present invention also relates to a method of controlling animal pests and protecting a useful plant or a part of a useful plant in need of protection from animal pest damage, the method comprising applying to an animal pest or an environment thereof an effective amount of a composition comprising a biologically pure culture of a Bacillus thuringiensis strain or a cell-free preparation thereof.Type: ApplicationFiled: November 14, 2019Publication date: January 13, 2022Inventors: Lorena FERNANDEZ, Punita JUNEJA, Reed Nathan ROYALTY, Bjorn A. TRAAG, Evelien Van Ekert, Emily L. WHITSON-WHENNEN
-
Publication number: 20210244031Abstract: The present invention provides a composition comprising a biologically pure culture of a Paenibacillus sp. strain comprising a mutant DegU lacking a functional receiver domain or a functional DNA binding domain and/or a mutant DegS lacking a functional single binding domain or a functional ATPase domain with decreased viscosity in a liquid culture. Also provided is a method of identifying a Paenibacillus sp. mutant derivative strain with decreased viscosity in a liquid culture compared to a Paenibacillus sp. parental strain with a visual screen for mutant isolates with a non-mucoid morphology.Type: ApplicationFiled: May 8, 2019Publication date: August 12, 2021Inventors: Jennifer Anne COLLINS, Jesus F. SANCHEZ, James L. WALLER, Bjorn A. TRAAG, Sara K. HOTTON, Tony J. TEGELER
-
Publication number: 20210238610Abstract: Signal sequences useful for targeting proteins and peptides to the surface of endospores produced by Paenibacillus family members and methods of using the same are provided. The display of heterologous molecules, such as peptides, polypeptides and other recombinant constructs, on the spore surface of Paenibacillus family members, using particular N-terminal targeting sequences and derivatives of the same, are also provided.Type: ApplicationFiled: March 30, 2021Publication date: August 5, 2021Inventors: Damian CURTIS, Benjamin L. GOLOMB, Dilara ALLY, Florencia A. FICARRA, Rauf SALAMZADE, Bjorn A. TRAAG
-
Patent number: 10988769Abstract: Signal sequences useful for targeting proteins and peptides to the surface of endospores produced by Paenibacillus family members and methods of using the same are provided. The display of heterologous molecules, such as peptides, polypeptides and other recombinant constructs, on the spore surface of Paenibacillus family members, using particular N-terminal targeting sequences and derivatives of the same, are also provided.Type: GrantFiled: November 15, 2018Date of Patent: April 27, 2021Assignee: Bayer CropScience LPInventors: Damian Curtis, Benjamin L. Golomb, Dilara Ally, Florencia A. Ficarra, Rauf Salamzade, Bjorn A. Traag
-
Publication number: 20200054023Abstract: The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof comprising at least one Paeniserine and at least one Paeniprolixin. Also provided are isolated compounds and methods of treating a plant to control a plant disease with the disclosed compositions and compounds.Type: ApplicationFiled: October 31, 2019Publication date: February 20, 2020Inventors: Jeremy BEAU, Daniel M. JOO, Patrick SCHWIENTEK, Colleen S. TAYLOR, Bjorn A. TRAAG
-
Patent number: 10499656Abstract: The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof comprising at least one Paeniserine and at least one Paeniprolixin. Also provided are isolated compounds and methods of treating a plant to control a plant disease with the disclosed compositions and compounds.Type: GrantFiled: November 14, 2018Date of Patent: December 10, 2019Assignee: Bayer CropScience LPInventors: Jeremy Beau, Daniel M. Joo, Patrick Schwientek, Colleen S. Taylor, Bjorn A. Traag
-
Publication number: 20190144874Abstract: Signal sequences useful for targeting proteins and peptides to the surface of endospores produced by Paenibacillus family members and methods of using the same are provided. The display of heterologous molecules, such as peptides, polypeptides and other recombinant constructs, on the spore surface of Paenibacillus family members, using particular N-terminal targeting sequences and derivatives of the same, are also provided.Type: ApplicationFiled: November 15, 2018Publication date: May 16, 2019Inventors: Damian CURTIS, Benjamin L. GOLOMB, Dilara ALLY, Florencia A. FICARRA, Rauf SALAMZADE, Bjorn A. TRAAG
-
Publication number: 20190069557Abstract: The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof comprising at least one Paeniserine and at least one Paeniprolixin. Also provided are isolated compounds and methods of treating a plant to control a plant disease with the disclosed compositions and compounds.Type: ApplicationFiled: November 14, 2018Publication date: March 7, 2019Inventors: Jeremy BEAU, Daniel M. JOO, Patrick SCHWIENTEK, Colleen S. TAYLOR, Bjorn A. TRAAG
-
Patent number: 10159257Abstract: The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof comprising at least one Paeniserine and at least one Paeniprolixin. Also provided are isolated compounds and methods of treating a plant to control a plant disease with the disclosed compositions and compounds.Type: GrantFiled: January 18, 2018Date of Patent: December 25, 2018Assignee: Bayer CropScience LPInventors: Jeremy Beau, Daniel M. Joo, Patrick Schwientek, Colleen S. Taylor, Bjorn A. Traag
-
Publication number: 20180146682Abstract: The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof comprising at least one Paeniserine and at least one Paeniprolixin. Also provided are isolated compounds and methods of treating a plant to control a plant disease with the disclosed compositions and compounds.Type: ApplicationFiled: January 18, 2018Publication date: May 31, 2018Inventors: Jeremy BEAU, Daniel M. JOO, Patrick SCHWIENTEK, Colleen S. TAYLOR, Bjorn A. TRAAG
-
Patent number: 9883676Abstract: The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof comprising at least one Paeniserine and at least one Paeniprolixin. Also provided are isolated compounds and methods of treating a plant to control a plant disease with the disclosed compositions and compounds.Type: GrantFiled: March 23, 2016Date of Patent: February 6, 2018Assignee: Bayer CropScience LPInventors: Jeremy Beau, Daniel M. Joo, Patrick Schwientek, Colleen S. Taylor, Bjorn A. Traag
-
Publication number: 20160278388Abstract: The present invention relates to a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain comprising a variant fusaricidin synthetase lacking a functional adenylation domain in the third module. The present invention also provides a composition comprising a biologically pure culture of a fungicidal Paenibacillus sp. strain or a cell-free extract thereof comprising at least one Paeniserine and at least one Paeniprolixin. Also provided are isolated compounds and methods of treating a plant to control a plant disease with the disclosed compositions and compounds.Type: ApplicationFiled: March 23, 2016Publication date: September 29, 2016Inventors: Jeremy BEAU, Daniel M. JOO, Patrick SCHWIENTEK, Colleen S. TAYLOR, Bjorn A. TRAAG